Similar Papers

Paper Title
Journal
Date
Author
Oxaliplatin in the adjuvant treatment of colon cancer
Mary Kay Barton
CA: A Cancer Journal for Clinicians | VOL. 62
Mary Kay BartonMary Kay Barton
16 Nov 2011
Translating IDEA to Practice and Beyond: Managing Stage II and III Colon Cancer.
Sharlene Gill ... Christine M. Veenstra
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting | VOL. 39
Sharlene Gill, et. al.Sharlene Gill ... Christine M. Veenstra
01 May 2019
Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol).
Garry Graham ... Richard Day
Current Pharmaceutical Design | VOL. 8
Garry Graham, et. al.Garry Graham ... Richard Day
01 Jun 2002
Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis
Z Nikolic-Tomasevic ... J Cassidy
Cancer Chemotherapy and Pharmacology | VOL. 56
Z Nikolic-Tomasevic, et. al.Z Nikolic-Tomasevic ... J Cassidy
26 Jul 2005
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
89P Spatial analysis using MultiOmyx hyperplex assay reveals high prevalence of mature tertiary lymphoid structure (TLS) and PDL1 expression in the MSI-high colorectal carcinoma (CRC)
Q Au ... V Chizhevsky
Annals of Oncology | VOL. 35
Q Au, et. al.Q Au ... V Chizhevsky
01 Dec 2024
276MO Epidemiology, treatment (tx) patterns, and clinical outcomes of patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) in Taiwan: A retrospective cohort study
C-T Wu ... L-N Chien
Annals of Oncology | VOL. 35
C-T Wu, et. al.C-T Wu ... L-N Chien
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.